IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Dr Reddys Laboratories

NSE:DRREDDY · ISIN INE089A01031

Close
₹1,142.3
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Dr Reddys Laboratories

Financials

RevenueN/APrior unavailable
Profit before taxN/APrior unavailable
Profit after taxN/APrior unavailable
EPSN/APrior unavailable
Structured filings

Reported financial periods

Exchange XBRL
MetricQuarter · FY27 · 30 Jun 26Quarter · FY26 · 31 Mar 26Quarter · FY26 · 31 Dec 25Half year · FY26 · 30 Sept 25Quarter · FY26 · 30 Jun 25FY25 · 31 Mar 25
RevenueN/A₹7,546.4 Cr₹8,753.4 Cr₹8,828.3 CrN/AN/A
Profit before taxN/A₹195.1 Cr₹1,540.9 Cr₹1,738.5 CrN/AN/A
Profit after taxN/A₹221.3 Cr₹1,189.6 Cr₹1,336.8 CrN/AN/A
Finance costN/A₹105.7 Cr₹94.4 Cr₹90.7 CrN/AN/A
ImpairmentN/AN/AN/AN/AN/AN/A
EPSN/A₹2.65₹14.53₹16.18N/AN/A
₹ crore except EPS · consolidated · preferred filing per periodBSE XBRL
Accounting lens

What deserves analyst attention

Research framework
Period comparability

Confirm quarterly, year-to-date and annual periods before calculating growth. The table preserves the exchange period labels.

Standalone vs consolidated

Treat scope changes as breaks in comparability and open the linked XBRL before relying on a trend.

Company-specific concepts

Sector metrics and accounting choices require additional facts beyond this common cross-company layer.